← Back to headlines
COMPASS Pathways' Psilocybin Asset for Depression Receives Commissioner Voucher
COMPASS Pathways announced that its psilocybin asset, intended for the treatment of depression, has been awarded a Commissioner voucher. This signifies a significant step in its development.
24 Apr, 14:54 — 24 Apr, 14:54
Sources
Showing 1 of 1 sources
